1. Home
  2. Genetic Insights
  3. Am I a good candidate for GeneSight® testing?

Am I a good candidate for GeneSight® testing?

Genetic Insights

Am I a Good Candidate for GeneSight Testing?

The GeneSight test is a genetic test that can help inform your doctor about genes that may affect how you metabolize or respond to certain medications commonly used to treat depression, anxiety, ADHD and other mental health conditions. The test is intended to supplement other information considered by a doctor as part of a comprehensive medical evaluation. Your psychiatrist, primary care physician, or other healthcare provider can determine if you are a good candidate for this testing.

Who Qualifies for GeneSight Testing?

Patients who have failed one or more medications:

GeneSight test results were validated among patients in clinical trials who were not responding to their medications.1–5  If you are a patient who has failed one or more medications, the GeneSight test can provide a roadmap for your healthcare provider to identify medications or medication classes to which you are most likely to respond.

Elderly patients and those with liver damage:

Elderly patients6 and patients with liver damage7 may have impaired production of liver enzymes, which can affect the rate a drug is metabolized and intensify the effects of genetic variations.  GeneSight testing gives healthcare providers genetically informed dosing guidance that can be used in addition to their revised dosing range for these patients. The GeneSight test has also been shown to significantly reduce polypharmacy (the taking of multiple medications)5, which can be common in elderly patients.

Patients who are very sensitive to medications:

Side effects from medications may result from the way a drug interacts with your body, the way your body impacts a drug, or even from psychological factors8. Many healthcare providers use the GeneSight test to shed light on this process for potential solutions.

When Should Caution Be Used with the GeneSight type?

Patients who have failed numerous medications in multiple classes:

The GeneSight test may explain why you have failed past medications and may validate your experience. If you have already tried many medications, the GeneSight test is less likely to identify a medication you have not yet tried. However, it may identify medications that a healthcare provider may re-try at an adjusted dose.

Patients with a liver transplant:

The GeneSight test looks at the DNA of the patient, while a transplanted liver has the DNA of the donor.

The GeneSight test provides accurate information regarding how medications used to treat depression, anxiety, ADHD and other psychiatric conditions affect your body. However, your healthcare provider will not gain useful information from the part of the test that reports how your body breaks down medications. This is because it reflects how you would break down medications based on your DNA, not the donor’s DNA.

Since the overall results of the GeneSight test depend on both parts of the test, the report that separates medications into the green, yellow, and red categories may not be used by your provider to guide medication decisions.

Therefore, liver transplant patients should only consider the GeneSight test if their healthcare provider believes benefit can be gained from the part of the test covering how certain medications impact the patient’s body.

Who is Not Appropriate for the GeneSight test?

Patients who are already doing well on their current medications are not ideal candidates for the GeneSight test.

The GeneSight test should be used when your healthcare provider is considering adjusting, augmenting or discontinuing your medication. 

Questions?

For more information on how the GeneSight test can help you and your physician, visit genesight.com, email us at [email protected], or phone 855.891.9415.

References

  1. Hall-Flavin, D. K. et al. Using a pharmacogenomic algorithm to guide the treatment of depression. Transl. Psychiatry 2, e172 (2012).
  2. Hall-Flavin, D. K. et al. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet. Genomics 23, 535–48 (2013).
  3. Winner, J., Allen, J. D., Anthony Altar, C. & Spahic-Mihajlovic, a. Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl. Psychiatry 3, e242 (2013).
  4. Winner, J. G., Carhart, J. M., Altar, C. A., Allen, J. D. & Dechairo, B. M. A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder. Discov. Med. 16, 219–27 (2013).
  5. Winner, J. G. et al. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a one year prospective evaluation. Curr. Med. Res. Opin. 1–30 (2015). doi:10.1185/03007995.2015.1063483
  6. Sotaniemi, E. A., Arranto, A. J., Pelkonen, O. & Pasanen, M. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions. Clin. Pharmacol. Ther. 61, 331–339 (1997).
  7. Prescott, L. F., Forrest, J. a, Adjepon-Yamoah, K. K. & Finlayson, N. D. Drug metabolism in liver disease. J. Clin. Pathol. Suppl. (R. Coll. Pathol). 9, 62–65 (1975).
  8. Mitsikostas, D. D., Mantonakis, L. & Chalarakis, N. Nocebo in clinical trials for depression: A meta-analysis. Psychiatry Res. 215, 82–86 (2014).

 

    Learn more

    Learn more about GeneSight
    How to talk to your provider
    View our clinical studies

    Take the next step with the GeneSight test

    Take a step closer to getting the GeneSight test or registering to provide the test to your patients. We will follow up with additional information either via email or phone.

    The GeneSight test must be ordered by a registered clinician. If you are a patient, caregiver or office staff who would like a clinician to be registered to administer the GeneSight test, please include their name and contact information.

    If you are a current registered provider or tested patient, please contact us.

    Take the Next Step - PD

    1. Step 1
    2. Step 2
    3. Step 3
    Please provide us with your name



    1. Step 1
    2. Step 2
    3. Step 3
    Please provide contact and clinic information
    Please provide contact information

    We are asking for Date of Birth for data verification purposes.










    We are asking for Date of Birth for data verification purposes.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.







    Your clinician who is currently managing your medication and making treatment decisions can order your GeneSight test.

    If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.

    Please provide your clinician's information
    The GeneSight test must be ordered by your clinician








    1. Step 1
    2. Step 2
    3. Step 3

    How can we help?
    When completed, we'll follow up with more information
    Please let us know how we can best help you
    When completed, we'll follow up with more information

    Already taken the GeneSight test and need access to your results?








    Contact Information

    By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Take the Next Step” page you agree to the possible transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be utilized for the sole purpose it was submitted for and governed by our Privacy Notice.